Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
Following successful completion of full set of clinical studies of proposed rituximab biosimilar candidate DRL_RI, Dr. Reddy’s will now prepare to file in the United States, European Union and other regions
The AGE1.CR.pIX cell line is derived from primary cells of a duck embryo and was designed to comply with health authority guidelines
The company is excited about the strategic progress that the company has made so far and are confident of delivering better business outcomes
Through the new agreements, Cristal Therapeutics and McSAF will gain access to Lonza’s integrated bioconjugates offering and will be able to leverage Lonza’s expertise in developing and manufacturing bioconjugates
This donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba
Swiftmelt 1515-I meets performance requirements and secures skin attachment
Merck intends to complete today the acquisition of Imago through a merger of Merck’s wholly owned subsidiary with and into Imago
The new project further expands the partner's long-term collaboration on new technologies for R&D
Subscribe To Our Newsletter & Stay Updated
